WO2009015799A3 - Détection de la résistance au platine - Google Patents
Détection de la résistance au platine Download PDFInfo
- Publication number
- WO2009015799A3 WO2009015799A3 PCT/EP2008/005965 EP2008005965W WO2009015799A3 WO 2009015799 A3 WO2009015799 A3 WO 2009015799A3 EP 2008005965 W EP2008005965 W EP 2008005965W WO 2009015799 A3 WO2009015799 A3 WO 2009015799A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- platinum
- detection
- platinum resistance
- patient
- sensitive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne un procédé servant à classer un patient comme sensible ou résistant au platine, l'utilisation du profil d'expression d'un sous-groupe de gènes pour classer un patient comme sensible ou résistant au platine, ainsi qu'un procédé pour l'identification de gènes informatifs permettant de classer un patient comme sensible ou résistant au platine.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE200710036404 DE102007036404A1 (de) | 2007-07-27 | 2007-07-27 | Nachweis der Platinresistenz |
DE102007036404.2 | 2007-07-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009015799A2 WO2009015799A2 (fr) | 2009-02-05 |
WO2009015799A3 true WO2009015799A3 (fr) | 2009-06-11 |
Family
ID=40104652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/005965 WO2009015799A2 (fr) | 2007-07-27 | 2008-07-21 | Détection de la résistance au platine |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102007036404A1 (fr) |
WO (1) | WO2009015799A2 (fr) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060019268A1 (en) * | 2004-03-26 | 2006-01-26 | Research Development Foundation | Molecular markers of cisplatin resistance in cancer and uses thereof |
US20060094012A1 (en) * | 2002-07-31 | 2006-05-04 | University Of Southern California | Polymorphisms for predicting disease and treatment outcome |
-
2007
- 2007-07-27 DE DE200710036404 patent/DE102007036404A1/de not_active Ceased
-
2008
- 2008-07-21 WO PCT/EP2008/005965 patent/WO2009015799A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060094012A1 (en) * | 2002-07-31 | 2006-05-04 | University Of Southern California | Polymorphisms for predicting disease and treatment outcome |
US20060019268A1 (en) * | 2004-03-26 | 2006-01-26 | Research Development Foundation | Molecular markers of cisplatin resistance in cancer and uses thereof |
Non-Patent Citations (14)
Title |
---|
AGARWAL ET AL: "Expression profiling and individualisation of treatment for ovarian cancer", CURRENT OPINION IN PHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 6, no. 4, 1 August 2006 (2006-08-01), pages 345 - 349, XP005539061, ISSN: 1471-4892 * |
BERNARDINI M ET AL: "HIGH-RESOLUTION MAPPING OF GENOMIC IMBALANCE AND IDENTIFICATION OF GENE EXPRESSION PROFILES ASSOCAITED WITH DIFFERENTIAL CHEMOTHERAPY RESPONSE IN SEROUS EPITHELIAL OVARIAN CANCER", NEOPLASIA, DOYMA, BARCELONA, ES, vol. 7, no. 6, 1 June 2005 (2005-06-01), pages 603 - 613, XP008068059, ISSN: 0212-9787 * |
CHEN Z ET AL: "CORRELATION OF CISPLATIN SENSITIVITY WITH DIFFERENTIAL ALTERATION OF EGFR EXPRESSION IN HEAD AND NECK CANCER CELLS", ANTICANCER RESEARCH, HELENIC ANTICANCER INSTITUTE, ATHENS, vol. 20, no. 2A, 1 March 2000 (2000-03-01), pages 899 - 902, XP009012770, ISSN: 0250-7005 * |
DAHL EDGAR ET AL: "Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 1 JUL 2006, vol. 12, no. 13, 1 July 2006 (2006-07-01), pages 3950 - 3960, XP002508551, ISSN: 1078-0432 * |
DE SMET F ET AL: "Predicting the clinical behavior of ovarian cancer from gene expression profiles.", INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER : OFFICIAL JOURNAL OF THE INTERNATIONAL GYNECOLOGICAL CANCER SOCIETY 2006 JAN-FEB, vol. 16 Suppl 1, January 2006 (2006-01-01), pages 147 - 151, XP002508552, ISSN: 1048-891X * |
DRESSMAN HOLLY K ET AL: "An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.", JOURNAL OF CLINICAL ONCOLOGY : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY 10 FEB 2007, vol. 25, no. 5, 10 February 2007 (2007-02-10), pages 517 - 525, XP002519673, ISSN: 1527-7755 * |
FEHRMANN RUDOLF S N ET AL: "Profiling studies in ovarian cancer: a review.", THE ONCOLOGIST AUG 2007, vol. 12, no. 8, August 2007 (2007-08-01), pages 960 - 966, XP002519672, ISSN: 1083-7159 * |
HELLEMAN JOZIEN ET AL: "Molecular profiling of platinum resistant ovarian cancer.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER 15 APR 2006, vol. 118, no. 8, 15 April 2006 (2006-04-15), pages 1963 - 1971, XP002519674, ISSN: 0020-7136 * |
KOMATSU MASAAKI ET AL: "Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers.", MOLECULAR CANCER THERAPEUTICS MAR 2006, vol. 5, no. 3, March 2006 (2006-03-01), pages 767 - 775, XP002519676, ISSN: 1535-7163 * |
MACLEOD KENNETH ET AL: "Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer", CANCER RESEARCH, vol. 65, no. 15, August 2005 (2005-08-01), pages 6789 - 6800, XP002519751, ISSN: 0008-5472 * |
PETERS DAVID ET AL: "Genome-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells.", MOLECULAR CANCER THERAPEUTICS OCT 2005, vol. 4, no. 10, October 2005 (2005-10-01), pages 1605 - 1616, XP002519675, ISSN: 1535-7163 * |
RICHARDSON ET AL: "Drug resistance in ovarian cancer: The emerging importance of gene transcription and spatio-temporal regulation of resistance", DRUG RESISTANCE UPDATES, CHURCHILL LIVINGSTONE, EDINBURGH, GB, vol. 8, no. 5, 1 October 2005 (2005-10-01), pages 311 - 321, XP005182400, ISSN: 1368-7646 * |
ROBERTS D ET AL: "Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells", BRITISH JOURNAL OF CANCER, vol. 92, no. 6, 28 March 2005 (2005-03-28), pages 1149 - 1158, XP002519671, ISSN: 0007-0920 * |
TAKEUCHI ET AL: "Cloning and characterization of DPPL1 and DPPL2, representatives of a novel type of mammalian phosphatidate phosphatase", GENE, ELSEVIER, AMSTERDAM, NL, vol. 399, no. 2, 2 June 2007 (2007-06-02), pages 174 - 180, XP022190607, ISSN: 0378-1119 * |
Also Published As
Publication number | Publication date |
---|---|
DE102007036404A1 (de) | 2009-01-29 |
WO2009015799A2 (fr) | 2009-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0817189A2 (pt) | Sensores de teste de multi-região e de potencial, métodos, e sistemas | |
EP2286175A4 (fr) | Détection et classification par interférométrie de défauts | |
MX2010003424A (es) | Medicion de propiedades mecanicas. | |
EP2164086A4 (fr) | Indicateur, détecteur et procédé de détection | |
WO2011065980A3 (fr) | Colorants pour l'analyse de l'agrégation de protéines | |
GB2481950B (en) | Surface microstructure measurement method, surface microstructure measurement data analysis method and surface microstructure measurement system. | |
DK2438446T3 (da) | Fremgangsmåder, reagenser og kits til flowcytometrisk immunfænotypebestemmelse | |
WO2008031041A3 (fr) | Signature de gène de mélanome | |
BRPI1013896A2 (pt) | Célula de levedura, e, métodos para produzir um composto isoprenóide e para detectar em uma amostra biológica a presença ou ausência de uma célula microbiana geneticamente. | |
WO2010077304A3 (fr) | Procédés de caractérisation de microorganismes sur des milieux solides ou semi-solides | |
WO2009048673A3 (fr) | Confinement stochastique pour détecter, manipuler, et utiliser des molécules et des organismes | |
DE602008006318D1 (de) | Element zur optischen Erfassung, Antriebsverfahren dafür und Sonde zur optischen Erfassung mit dem Element zur optischen Erfassung | |
WO2011087789A3 (fr) | Procédés de détection de microorganismes | |
EP2216747A3 (fr) | Procédé et appareil pour associer informations démographiques et géographiques aux relations d'influence de consommateurs | |
EP2229028B8 (fr) | Appareil de mesure d'un échantillon biologique et système de mesure d'un échantillon biologique le comprenant | |
NZ592994A (en) | Diagnostic test for Streptococcus equi comprising assessing the presence or absence of the S. equi eqbE gene | |
HK1142675A1 (en) | Method for improving the ability to detect materials in an x-ray test system, and x-ray test system | |
WO2010075360A3 (fr) | Procédé de détection de sepsie | |
NZ589251A (en) | Novel marker for detection of bladder cancer | |
IL223077A0 (en) | Novel as160-like protein, test systems, methods and uses involving it for the identification of diabetes type 2 therapeutics | |
WO2012082742A3 (fr) | Détection du cancer par des anticorps anti-ccl25 et anti-ccr9 | |
WO2012024546A3 (fr) | Incorporation de mesures de l'état de santé dans l'analyse et l'interprétation de données de réponse biologique fonctionnelle | |
EP2208795A4 (fr) | Procédé de détection d'acide nucléique, et coffret de détection d'acide nucléique | |
WO2011017419A3 (fr) | Systèmes et procédés de contrôle de corrosion dans un puits | |
WO2009100447A3 (fr) | Détection d'enzymes de dégradation et de biomolécules dans des liquides organiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08784930 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08784930 Country of ref document: EP Kind code of ref document: A2 |